Iranian Company Makes Glass Reactor for Pharmaceutical Industries

Iranian Company Makes Glass Reactor for Pharmaceutical Industries

TEHRAN (ANA)- An Iranian knowledge-based company active in the field of manufacturing laboratory equipment succeeded in making a glass chemical reactor for the pharmaceutical industry with a 40% reduction in production costs.
News ID : 6878

“Construction of an Iran-made portable chemical reactor is one of our company’s achievements. We produced it based on the needs of laboratories of certain industries like food, pharmaceutical, and chemical industries and with the aim of ending the dependence of Iran in the field of laboratory equipment,” said Seyed Ali Sajjadi, the managing director of the knowledge-based company.

He added that the product has been made at about 30% to 40% lower costs than imported samples.

Noting that the reactor has been made of glass, Sajjadi said, “In this reactor, it is possible to see all the chemical operations during the process. This feature has made it possible to take necessary and quick actions as soon as the color of the chemical reaction or other changes change. The glass parts of the reactor do not have any side effects on the operation and chemical compounds, and it is easy to produce medicine in it.”

The chairman of the Iranian pharmaceutical Industries Syndicates announced in July that 71% of raw material needed by domestic pharmaceutical companies were produced inside the country.

Faramarz Ekhterayee made the remarks at the opening of the 6th Pharmex international pharmaceutical exhibition which was held on 4-7 July 2024 in Tehran.

“71% of the need for pharmaceutical raw materials of the country's pharmaceutical companies is supplied domestically, and Iranian companies have a good capacity to produce effective pharmaceutical ingredients,” the syndicate head said.

He added that Iran will be able to become a major exporter of effective medicinal substances in the next three years.

"Iran has grown powerful in the production of raw materials of medicine and domestic production prices are much lower than other countries," Ekhterayee added.

“Iran is in a favored position in terms of the production of raw materials of medicine, but we have not reached a suitable ground for exports. Considering the high capabilities of domestic producers, the best option is to move towards export. To solve this problem, we have to overcome the barriers put by sanctions through experienced solutions,” he concluded.

4155/v

Send comment